BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21503571)

  • 1. The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma.
    Cordes C; Häsler R; Werner C; Görögh T; Röcken C; Hebebrand L; Kast WM; Hoffmann M; Schreiber S; Ambrosch P
    Int J Oncol; 2011 Jul; 39(1):185-91. PubMed ID: 21503571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
    Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
    Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma.
    Quabius ES; Görögh T; Fischer GS; Hoffmann AS; Gebhard M; Evert M; Beule A; Maune S; Knecht R; Óvári A; Durisin M; Hoppe F; Röcken C; Hedderich J; Ambrosch P; Hoffmann M
    Cancer Lett; 2015 Feb; 357(1):339-345. PubMed ID: 25462861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
    Pierce Campbell CM; Giuliano AR; Torres BN; O'Keefe MT; Ingles DJ; Anderson RL; Teras LR; Gapstur SM
    Oral Oncol; 2016 Apr; 55():1-5. PubMed ID: 27016010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of smoking habit, SLPI and AnxA2 in HPV associated head and neck and other cancers.
    Hoffmann M; Quabius ES; Fabian A; Laudien M; Ambrosch P
    Cancer Treat Res Commun; 2021; 26():100299. PubMed ID: 33387869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.
    Sayers KT; Brooks AD; Sayers TJ; Chertov O
    PLoS One; 2014; 9(8):e104223. PubMed ID: 25110884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma.
    Wen J; Nikitakis NG; Chaisuparat R; Greenwell-Wild T; Gliozzi M; Jin W; Adli A; Moutsopoulos N; Wu T; Warburton G; Wahl SM
    Am J Pathol; 2011 Jun; 178(6):2866-78. PubMed ID: 21641406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI.
    Quabius ES; Merz I; Görögh T; Hedderich J; Haag J; Röcken C; Ambrosch P; Hoffmann M
    Papillomavirus Res; 2017 Dec; 4():26-34. PubMed ID: 29179866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.
    Zhang X; Liu SS; Ma J; Qu W
    Pathol Res Pract; 2023 Aug; 248():154633. PubMed ID: 37356220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of upregulated genes in oral squamous cell carcinomas.
    Lessa RC; Campos AH; Freitas CE; Silva FR; Kowalski LP; Carvalho AL; Vettore AL
    Head Neck; 2013 Oct; 35(10):1475-81. PubMed ID: 22987617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer.
    Cheng WL; Wang CS; Huang YH; Liang Y; Lin PY; Hsueh C; Wu YC; Chen WJ; Yu CJ; Lin SR; Lin KH
    Int J Cancer; 2008 Oct; 123(8):1787-96. PubMed ID: 18688858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
    Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
    Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
    Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
    Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
    Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer.
    Liu G; Yang J; Zhao Y; Wang Z; Xing B; Wang L; Shi D
    World J Surg Oncol; 2014 Dec; 12():369. PubMed ID: 25441765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro.
    Zhu Z; Xu X; Yu Y; Graham M; Prince ME; Carey TE; Sun D
    Mol Pharm; 2010 Aug; 7(4):1283-90. PubMed ID: 20540527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion.
    Mikami Y; Fukushima A; Komiyama Y; Iwase T; Tsuda H; Higuchi Y; Hayakawa S; Kuyama K; Komiyama K
    Cancer Lett; 2016 Aug; 379(1):84-93. PubMed ID: 27238568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.